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Abstract: Excited delirium, sometimes referred to as agitated or excited delirium, is the label 
assigned to the state of acute behavioral disinhibition manifested in a cluster of behaviors that 
may include bizarreness, aggressiveness, agitation, ranting, hyperactivity, paranoia, panic, 
violence, public disturbance, surprising physical strength, profuse sweating due to hyper-
thermia, respiratory arrest, and death. Excited delirium is reported to result from substance 
intoxication, psychiatric illness, alcohol withdrawal, head trauma, or a combination of these. 
This communication reviews the history of the origins of excited delirium, selected research 
related to its causes, symptoms, management, and the links noted between it and selected medical 
and psychiatric conditions. Excited delirium involves behavioral and physical symptoms that 
are also observed in medical and psychiatric conditions such as rhabdomyolysis, neuroleptic 
malignant syndrome, and catatonia. A useful contribution of this communication is that it links 
the state of excited delirium to conditions for which there are known and effective medical and 
psychiatric interventions.
Keywords: excited delirium, excited states, cocaine misuse, restraint or in custody deaths
History
The state referred to as agitated or excited delirium has its origins in the mid 1970s 
when cocaine intoxication was reported to result in cocaine psychoses.1 Aspects of these 
psychoses and more severe and lethal physical symptoms such as acute toxic psycho-
sis, seizures, coma, respiratory collapse, and death were also observed in individuals 
attempting to smuggle packets of cocaine that leaked or broke in their bodies.2 Excited 
delirium was explicitly described in 1985 as a state resulting from cocaine intoxication 
involving acute intense paranoia, bizarreness, violence, surprising physical strength, 
hyperthermia, and fatal respiratory collapse within minutes or hours after restraint.3 
An individual hospitalized in an excited and delirious state might meet the criteria for 
substance intoxication delirium and mania. Substance intoxication delirium involves 
disorientation, disruption of awareness, inability to attend, confusion, perceptual dif-
fi culties, and inappropriate responses to changing situations. The excitement can be 
seen as similar to the excitement of the acute phase of bipolar mania with grandiosity, 
distractibility and psychomotor agitation.4
Excited delirium has been acknowledged as being among several acute excited 
states such as catatonic excitement or delirious mania.5
In this regard, the behavioral excitement aspect of excited delirium is quite 
similar to the excitement seen in catatonic excitement. Patients’ behavior in catatonic 
excitement may be “stereotypic with sudden outbursts of talking, singing, dancing, 
and tearing at their clothes. They become irritable and may damage objects or injure 
hospital staff ”.6 Taylor6 observes that catatonic excitement is diffi cult to differentiate 
from delirious mania. According to Fink,7 delirious mania is seen in the emergence 
of severe “excitement, grandiosity, emotional lability, delusions, and insomnia 
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characteristic of mania, and the disorientation and altered 
consciousness characteristic of delirium. Almost all patients 
exhibited signs of catatonia.” Catatonia signs may involve 
physical immobility seen as cataleptic or stuporousness, 
excessive purposeless physical activity, serious negativism 
or mutism, idiosyncratic voluntary movements, echolalia 
involving the repetition of words or phrases, or ecopraxia 
involving repetitive copying of another person’s movements.4 
The most likely catatonia signs manifested by persons in a 
state of excited delirium would be excitement manifested 
in excessive purposeless physical activity, idiosyncratic 
voluntary movements, echolalia and/or echopraxia.
Issues regarding excited delirium
Excited delirium has gained public notice because it has so 
often been among the post-mortem explanations offered by 
medical examiners in the deaths of individuals during the 
process of being restrained by law enforcement to be taken 
into custody or while being held in custody.8–16 Studies 
by medical examiners have focused on determining the 
causes of the deaths of individuals described as being in a 
state of excited delirium prior to and after being restrained 
and whether or how restraint may have played a role in the 
deaths of these individuals.17–19 The prevalence of agitated 
or excited delirium is uncertain and studies have tended to 
focus on deceased victims.11 An informative result of the 
studies is the fi nding that excited delirium is not only due 
to substance intoxication but also to psychiatric illness, 
alcohol withdrawal, head trauma or a combination of these 
conditions.8–11,14 The case presented below is an example 
of the context within which many persons in a state of 
excited delirium are encountered by law enforcement and 
emergency services.
A case of untreated excited 
delirium and sudden death
This case was abstracted from selected news articles by 
Babstock20–24 on a coroner’s inquest into the death of a man 
while police were restraining him in order for him to be re-
hospitalized. The 34-year-old man had a history of major 
psychiatric illness which was diagnosed as bipolar disorder 
when he was 18 years old. It is reported that treatment was 
occasionally affected by his use of marijuana, hashish, LSD, 
and amphetamines. During the several years before his death, 
this patient was seen every few weeks by a psychiatrist who 
described him as doing well or, at times, as hypomanic or 
depressed. He was an unpredictable patient who could not 
be depended upon to take his prescribed medication or avoid 
using marijuana. Hospitalization was required for a psychotic 
episode during which he had delusions of persecution and 
was ranting about religious topics. He was restricted to a 
locked unit for patients considered dangerous to self and 
others for two days. By the third day of hospitalization, he 
was transferred to an open unit on the basis of his improved 
demeanor and compliance with treatment. He was not 
permitted to leave the open unit–not even for a cigarette. 
Later on the same day that he had been transferred, at about 
9:00 PM, he walked off the unit telling a psychiatric attendant 
pursuing him that he was going for a cigarette. At 9:30 PM, 
it was determined that he had left the hospital and the police 
were notifi ed. He had apparently gotten a cab and requested to 
be taken to several places. The driver stopped the cab after the 
man grabbed the steering wheel. The patient left the cab and 
made his way to a lounge. At the lounge, he was reported to 
be talking to mirrors, asking questions and walking back and 
forth in front of the bar. His behavior caused the proprietor to 
call for police assistance. When the police arrived to return 
him to the hospital, he refused and attempted to avoid being 
restrained. He was described as sweating, breathing heavily, 
and with dilated pupils. His attempt to avoid restraint resulted 
in smashed tables and injury of a police offi cer. The police 
used pepper spray and Taser in attempting to restrain him. 
It took four offi cers to subdue him and almost immediately 
after being restrained he stopped breathing. Cardiopulmonary 
resuscitation was initiated and a call was made for emer-
gency medical assistance. Attempts to resuscitate him were 
unsuccessful. During the coroner’s inquest it was noted that 
he was obese, had asthma, an enlarged heart, and had eight 
Taser wounds. Ultimately, an expert’s testimony attributed 
his death to excited delirium. His history of substance misuse 
and psychiatric illness are two possible antecedents to his 
state of excited delirium. It is noteworthy that this case is 
similar in its outcome to many others in that the client died 
while being restrained to be taken into custody (eg, Bast15).
A diagnostic problem
Concern has been expressed that although the state of excited 
delirium is given as an explanation for in-custody deaths, it is 
currently not a recognized medical or psychiatric diagnosis 
according to either the Diagnostic and Statistical Manual of 
Mental Disorders (DSM-IVTR) of the American Psychiatric 
Association4 or the International Classifi cation of Diseases 
(ICD-9) of the World Health Organization.25–27 Yet it is 
important to note that a lack of recognition does not negate 
the seriousness of the behavioral and physical symptoms 
referred to as excited delirium. It is noteworthy that one 
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study found that only 18 of 214 individuals identifi ed as 
manifesting excited delirium died when restrained and taken 
into custody.12 Unfortunately, the study did not report if or 
whether the survivors were diagnosed or treated.
Rhabdomyolysis, neuroleptic 
malignant syndrome, and catatonia
Cocaine-intoxicated individuals in a state of excited 
delirium have been reported to have cocaine blood level 
concentrations ten times lower than individuals who died 
of cocaine overdoses without excited delirium. The excited 
delirium and lower cocaine levels is explained as due to 
modifi cations of dopamine processing resulting from habitual 
cocaine use.18 Studies have noted that survivors of cocaine 
intoxication with excited delirium have also been reported 
to develop rhabdomyolysis which results in skeletal muscle 
breakdown and leakage of muscle substance into the cir-
culatory system that has clinical similarities to neuroleptic 
malignant syndrome (NMS).17,18,28–30 Ruttenber and col-
leagues17 maintain that excited delirium and cocaine-induced 
rhabdomyolysis are aspects of the same syndrome that is 
likely due to chronic cocaine use. The issue of the clinical 
similarities between cocaine induced rhabdomyolysis and 
NMS points to the speculation of whether cocaine rhabdomy-
olysis is a form of NMS.29,31 Neuroleptic malignant syndrome 
is manifested in severe muscle rigidity, fever, cognitive 
confusion, elevated creatinine phosphokinase and/or white 
blood count levels allegedly related to the administration of 
neuroleptic medications.4,32 A 1991 study found that cocaine 
abusers treated with neuroleptics developed NMS whereas 
nonabusers did not.33 Khaldarov34 successfully treated a 
patient, with a history of cocaine abuse and recent treat-
ment with fl uphenazine, with lorazepam on the basis of the 
assumption that cocaine-associated rhabdomyolysis with 
hyperthermia and NMS are the same condition.
Lopez-Canino and Francis,35 in their review of the 
literature on drug-induced catatonia from the study of phen-
cyclidine intoxication by McCarron and colleagues,36 also 
noted an association between rhabdomyolysis and catatonia. 
Other studies have reported an association between psychosis 
(eg, mania and schizophrenia) involving overactivity, cata-
tonia and rhabdomyolysis.37–39 In sum, the literature appears 
to suggest some association between the state of excited 
delirium, rhabdomyolysis, NMS and even catatonia. Studies 
have also noted that NMS and catatonia seem to be different 
aspects of the same syndrome (cf, Fink;40 Carroll;41 Koch and 
colleagues42). Petrides and colleagues43 propose that NMS 
itself is a form of catatonia whose features are similar to those 
of malignant catatonia and that they may both benefi t from 
similar treatment.
The association researchers have established between 
excited delirium and the potentially life-threatening syn-
dromes of rhabdomyolysis, NMS, and catatonia give impetus 
to the need for critical emergency medical interventions when 
encountering a person thought to be in a state of excited 
delirium.
A case of treated excited delirium
Petrides and colleagues43 report on treating a patient “… in a 
state of excited delirium following intrethecal administration of 
an analgesic for chronic pain” (for the original report see Levin 
and colleagues45). Symptoms included purposeless agitation, 
stiffness, serious negativism or mutism, and staring. Creatine 
phosphokinase level remained elevated. His temperature was 
quite high and he required physical restraint. There was no 
benefi t from intravenous haloperidol, lorazepam, or midazolam. 
The delirium remained refractory and the patient required inten-
sive care with intubation and ventilation. By the 18th day of 
hospitalization it was determined that electroconvulsive therapy 
(ECT) should be initiated and fi ve treatments were administered 
during thee days. On the 21st day of hospitalization, after a 
fi nal ECT, he was able to interact with his wife. He improved 
and had no memory of his illness and was able to return to 
part-time work. After three months he was regarded as fully 
recovered (cf, Levin and colleagues45). Petrides and colleagues43 
retrospectively reported this patient as an example of someone 
manifesting “atypical catatonic features”. Interestingly, in the 
original case report there was no discussion of catatonia and 
the administration of ECT appears to have been initiated to 
treat the delirium (cf, Strömgren;45 Fink46). This is noteworthy 
in view of the fact that the DSM-IVTR guidelines for catatonia 
due to a medical condition would not apply to an individual 
manifesting a delirium to ensure that the medical source of 
the delirium is resolved.4 The success of the intervention in 
this instance suggests that even a delirium due to a medical 
condition refractory to other interventions may benefi t from 
those specifi cally designated for catatonia such as high doses 
of lorazepam (12 to 20 mg/day) or ECT when the lorazepam 
is not effective.
There are some similarities between the state of excited 
delirium and catatonia that may be best seen in examining 
case examples of catatonia when the catatonia involves agita-
tion and excessive physical or motor activity. Below are two 
case examples of catatonia in individuals with symptoms of 
agitation and excessive physical activity (cases from Ferrell 
and Williams47).
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Case examples of catatonia
Case A
This is the case of a 75-year-old woman with a history of 
major psychiatric illness, which was diagnosed as schizo-
phrenia when she was in her 20s. She subsequently suffered 
a hemorrhagic stroke from an anterior communicating artery 
aneurysm in her 20s. Both frontal lobes sustained extensive 
destruction and a more severe mental syndrome emerged 
after the stroke. Many years of psychiatric hospitalization 
resulted. The treatments initiated included 80 ECT treat-
ments, many hours of continuous baths, insulin coma therapy, 
various anti-psychotic medicines and assorted psychotropic 
drugs, including anticonvulsants. She had severe tardive 
dyskinesia. At age 75 an episode of extreme agitation with 
catatonic symptoms of constant motor activity, disrobing, 
marked negativism, echolalia and echopraxia occurred. Her 
creatine kinase value was 2400. Treatment was initiated 
by discontinuing her previously prescribed haloperidol and 
initiation of lorazepam up to 16 milligrams per day in divided 
doses. The catatonic syndrome remitted and did not recur. 
Treatment with low dose lorazepam was continued. Anti-
psychotic medications were not restarted and there was no 
return of psychotic symptoms.
Case B
A 74-year-old woman first experienced the onset of 
delusional symptoms at age 21. At that time, she was assessed 
and attained a full scale IQ of 70. Her symptoms were 
diagnosed as indications of schizophrenia. She recovered 
from this initial illness and lived a quiet productive life in 
the care of her family until age 51. After a “fl u-like illness,” 
she attempted to return to her assembly-line job where she 
was found standing mute and motionless on the line. She 
required hospitalization and received institutional care until 
her death almost 30 years later. While suffering a severe 
neuropsychiatric illness she manifested sustained periods of 
social withdrawal, posturing, and muteness. At age 74 she 
suffered an episode of severe excitement, agitation, delirium, 
sleeplessness and dehydration. The syndrome was life threat-
ening. Results of a magnetic resonance imaging (MRI) study 
revealed advanced cerebral atrophy without focal fi ndings 
as had several prior computed tomography (CT) scans. An 
electroencephalograph (EEG) was normal. There was a his-
tory of prior protracted periods of severe agitation and yelling 
as observed at age 74, though less severe. Prior treatment 
with medication was marginally successful, including trials 
of typical antipsychotic drugs, antidepressants, lithium, 
diphenhydramine, chloral hydrate, divalproex sodium, 
methylphenidate, and benzodiazepines. She responded well 
to six ECT treatments. After a relapse, she recovered with 
12 additional ECT treatments. The catatonia did not recur 
with clozapine prophylaxis during the remaining six years 
of her life. ECT treatment was regarded as life-saving for 
this patient.
In both the untreated and treated cases of excited delirium 
the symptoms were unexpected as were the symptoms of 
catatonia in the cases discussed above. The serious difference 
in the outcomes was the fact that the individuals – one in 
a state of excited delirium and two with catatonia – who 
were hospitalized were expeditiously diagnosed and treated. 
Regarding medical care and excited delirium, Stratton 
and colleagues12 have made the observation “… that 
unexpected sudden death when excited delirium victims 
are restrained in the out-of-hospital setting is not infrequent 
and can be associated with multiple predictable but usually 
uncontrollable factors.”
Discussion
It is noteworthy that excited delirium, NMS and catatonia 
may result in many physical symptoms that are similar such 
as profuse sweating, dehydration, electrolyte imbalance, 
fever, tachycardia, hypertension, rapid breathing, and the 
possibility of death without proper treatment.9,14,32,48–50
Treatment recommended for excited delirium, NMS and 
catatonia are quite similar. Selected aspects of the treatment 
approach for excited delirium reported here are based upon 
recommendations in Karch and Stephens,10 Petrides and 
colleagues43 (cf Levin and colleagues45), and Sztajnkrycer 
and Baez.14 Individuals manifesting excited delirium should 
be evaluated for their medical needs on an emergency basis. 
They should especially receive temperature, oximetry and 
cardiac monitoring. Temperature management interventions 
should be initiated as necessary. Due to the psychomotor 
agitation during the state of excited delirium, treatment with 
benzodiazepines, and possibly in high doses is recommended. 
Neuroleptics are not recommended due to the possible 
adverse infl uence on temperature regulation, seizure thresh-
old and arrhythmia. If benzodiazepines are not effective, ECT 
should be considered as it was in the excited delirium case 
reported by Petrides and colleagues.43
In sum, the association between the state of excited 
delirium and the potentially life-threatening syndromes of 
rhabdomyolysis, NMS and catatonia give impetus to the need 
for critical emergency medical care for persons encountered 
in a probable state of excited delirium. Rigorous effort should 
be aimed at establishing the best possible understanding of 
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relevant medical and psychiatric diagnosis. Correct diagnosis 
leads to rational and effective treatment. Research into 
understanding and managing excited delirium may receive 
considerable benefi t from examining the documentation 
on the diagnosis and care of persons with rhabdomyolysis, 
NMS and catatonia for which there are known and effective 
medical and psychiatric interventions.
Disclosure
The authors report no confl icts of interest in this work.
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